绝经因素与血清阴性及血清阳性类风湿关节炎风险的相关性:护士健康研究结果
基于护士健康研究(NHS 1976-2010、NHSII 1989-2011)随访数据,共确认1096例新发类风湿关节炎(RA)。研究发现绝经后女性血清阴性RA风险约为绝经前女性的2倍(合并HR 2.1,95%CI 1.4-3.0),早发自然绝经(≤44岁)与血清阴性RA风险升高相关(合并HR 2.4,95%CI 1.5-4.0),而绝经因素与血清阳性RA无显著关联。
要点
- 绝经后女性血清阴性RA风险较绝经前约增2倍(合并HR 2.1,95%CI 1.4-3.0)。
- ≤44岁自然绝经与血清阴性RA风险升高相关(合并HR 2.4,95%CI 1.5-4.0)。
- 绝经因素与血清阳性RA无显著关联,提示RA亚型病因可能不同。
核心结论
- 绝经后状态和早发自然绝经与血清阴性RA强烈相关,而与血清阳性RA仅 marginally 相关,提示RA亚型病因可能存在差异。
研究设计与样本
- 基于护士健康研究(NHS 1976-2010和NHSII 1989-2011)的前瞻性队列分析,NHS纳入120700名30-55岁女护士,NHSII纳入116430名25-42岁女护士,通过 biennial 问卷随访生活方式和疾病结局。
- 共确认1096例新发RA,血清阳性RA定义为RF阳性或ACPA阳性,血清阴性RA定义为RF阴性且ACPA阴性。
- 采用Cox比例风险模型计算多变量调整的风险比(HR)及95%置信区间(95%CI)。
主要发现
- 绝经后女性血清阴性RA风险较绝经前女性升高:NHS HR 1.8(95%CI 1.1-3.0),NHSII HR 2.4(95%CI 1.4-3.9),合并HR 2.1(95%CI 1.4-3.0)。
- ≤44岁自然绝经与血清阴性RA风险升高相关(合并HR 2.4,95%CI 1.5-4.0)。
- 绝经因素与血清阳性RA均无显著关联。
- 绝经激素治疗(PMH)使用与血清阴性或血清阳性RA风险无关联,但PMH使用≥8年与血清阳性RA风险升高相关(合并HR 1.4,95%CI 1.1-1.9)。
关键数值与推荐
- 血清阳性RA定义:RF阳性或ACPA阳性;血清阴性RA定义:RF阴性且ACPA阴性。
- 绝经后 vs 绝经前血清阴性RA合并HR 2.1(95%CI 1.4-3.0)。
- ≤44岁自然绝经血清阴性RA合并HR 2.4(95%CI 1.5-4.0)。
- PMH使用≥8年血清阳性RA合并HR 1.4(95%CI 1.1-1.9)。
临床怎么用
- 对绝经后女性尤其是早发自然绝经者,应关注血清阴性RA的筛查与早期识别。
- 评估RA风险时需区分血清学亚型,绝经因素主要与血清阴性RA相关。
- 长期(≥8年)绝经激素治疗者需留意血清阳性RA风险可能轻度升高。
局限性
- 研究人群为女护士,结果外推需谨慎。
- 观察性设计不能排除残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether menopausal factors are associated with the development of serologic rheumatoid arthritis (RA) phenotypes. METHODS: Data were analyzed from the Nurses' Health Studies (NHS; 1976-2010 and NHSII 1989-2011). A total of 120,700 female nurses ages 30-55 years in the NHS, and a total of 116,430 female nurses ages 25-42 years in the NHSII, were followed via biennial questionnaires on lifestyle and disease outcomes. In total, 1,096 incident RA cases were confirmed by questionnaire and chart review. Seropositive RA was defined as rheumatoid factor positive (RF) or antibodies to citrullinated protein antigen (ACPA) positive, and seronegative RA was defined as RF negative and ACPA negative. We used Cox proportional hazards models to obtain multivariable-adjusted hazard ratios (HRs) with 95% confidence intervals (95% CIs) of seropositive/seronegative RA associated with menopausal status, age at menopause, type of menopause, ovulatory years, and postmenopausal hormone therapy (PMH) use. RESULTS: Postmenopausal women had a 2-fold increased risk of seronegative RA, compared with premenopausal women (NHS: HR 1.8 [95% CI 1.1-3.0], NHSII: HR 2.4 [95% CI 1.4-3.9], and pooled HR 2.1 [95% CI 1.4-3.0]). Natural menopause at early age (≤44 years) was associated with an increased risk of seronegative RA (pooled HR 2.4 [95% CI 1.5-4.0]). None of the menopausal factors was significantly associated with seropositive RA. We observed no association between PMH use and the risk of seronegative or seropositive RA, except that PMH use of ≥8 years was associated with increased risk of seropositive RA (pooled HR 1.4 [95% CI 1.1-1.9]). CONCLUSION: Postmenopause and natural menopause at an early age were strongly associated with seronegative RA, but only marginally with seropositive RA, suggesting potential differences in the etiology of RA subtypes.
引用
- Bengtsson C, Malspeis S, Orellana C, et al. Association Between Menopausal Factors and the Risk of Seronegative and Seropositive Rheumatoid Arthritis: Results From the Nurses' Health Studies. Arthritis Care Res (Hoboken). 2017. PMID: 28085997. doi:10.1002/acr.23194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。